FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileMindMaze Therapeutics Holding S.A. Sponsored ADR
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RLFTY
MindMaze Therapeutics Holding S.A. Sponsored ADR Stock AnalysisComprehensive stock analysis for MindMaze Therapeutics Holding S.A. Sponsored ADR (RLFTY) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRLFTY
RLFTY
MindMaze Therapeutics Holding S.A. Sponsored ADR
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
RLFTY
  1. Home
  2. Stocks
  3. MindMaze Therapeutics Holding S.A. Sponsored ADR

MindMaze Therapeutics Holding S.A. Sponsored ADR

🇺🇸RLFTY•OTC

MindMaze Therapeutics Holding S.A. Sponsored ADR

🇺🇸RLFTY•OTC
Market cap
$11.96M

Your view on RLFTY

Mkt Cap
$11.96M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About MindMaze Therapeutics Holding S.A. Sponsored ADR

Industry
Biotechnology
Sector
Healthcare
CEO
Alexandre Capet
Headquarters
Bâtiment F2/F3, Geneva, CH
Industry
Biotechnology
Sector
Healthcare
CEO
Alexandre Capet
Headquarters
Bâtiment F2/F3, Geneva, CH
Description

MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for MindMaze Therapeutics Holding S.A. Sponsored ADR. Starting points for MindMaze Therapeutics Holding S.A. Sponsored ADR: EPS -$0.99, beta 0.73 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for MindMaze Therapeutics Holding S.A. Sponsored ADR. MindMaze Therapeutics Holding S.A. Sponsored ADR does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for MindMaze Therapeutics Holding S.A. Sponsored ADR. Trailing twelve-month EPS for MindMaze Therapeutics Holding S.A. Sponsored ADR stands at -$0.99. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for MindMaze Therapeutics Holding S.A. Sponsored ADR. MindMaze Therapeutics Holding S.A. Sponsored ADR has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold RLFTY12 companies
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
DTC.CNDefence Therapeutics Inc.HealthcareCNQ$40.5M
DTCFFDefence Therapeutics Inc.HealthcareOTC$22.9M
DTILPrecision BioSciences, Inc.HealthcareNASDAQ$206.7M
DVHGFDevonian Health Group Inc.HealthcareOTC$29.5M
DWTXDogwood Therapeutics, Inc.HealthcareNASDAQ$39.6M
DXB.AXDimerix LimitedHealthcareASX—
DYAIDyadic International, Inc.HealthcareNASDAQ$11.5M
DYNDyne Therapeutics, Inc.HealthcareNASDAQ$2.9B
EDITEditas Medicine, Inc.HealthcareNASDAQ$253.1M
EDSAEdesa Biotech, Inc.HealthcareNASDAQ$19.3M
EFTReFFECTOR Therapeutics, Inc.HealthcareOTC$941
EHOSEhouse Global, Inc.HealthcareOTC$10,127
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for MindMaze Therapeutics Holding S.A. Sponsored ADR. Coverage tracks MindMaze Therapeutics Holding S.A. Sponsored ADR within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of MindMaze Therapeutics Holding S.A. Sponsored ADR.

RLFTY AnalysisWeak
Past
1
Growth
1
Health
0
Profit
1
Value
0